drugset / Trial / NCT07011134

Timing of Aminophylline and Recovery in Pediatric Ambulatory Surgery

NCT07011134

Phase 3 Completed 60 enrolled Hany Mohammed El-Hadi Shoukat Mohammed
RandomizedParallel-groupTriple-blindSupportive care

Summary

Beyond its established use as a bronchodilator and therapy for apnea of prematurity, aminophylline has demonstrated utility in reversing the effects of anesthetics, enhancing recovery by accelerating respiratory and cognitive functions. Variations in dosage (1-6 mg/kg) have been explored, but questions persist regarding optimal timing and dosing for pediatric surgical populations to achieve maximal efficacy with minimal adverse effects. This randomized controlled study aims to evaluate the effect of early versus late aminophylline administration on recovery profiles in pediatric patients undergoing ambulatory surgery under sevoflurane anesthesia. Sixty children aged 4-12 years will be randomly allocated into three groups: Group (E) will receive aminophylline early intraoperatively, Group (L) will receive aminophylline late intraoperatively, and Group (C) will receive normal saline post-anesthetic discontinuation.

Timeline

Start
2025-06-15
Primary completion
2025-08-15
Completion
2025-08-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aminophylline Small molecule 5 mg/kg

Indications

No indication recorded.